Your session is about to expire
← Back to Search
Sonodynamic Therapy for Glioblastoma (GBM 001 Trial)
GBM 001 Trial Summary
This trial will explore if combining a drug with focused ultrasound can reduce GBM tumor cells with less damage to healthy cells.
GBM 001 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGBM 001 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GBM 001 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals below the age of 55 qualified to participate in this trial?
"According to the criteria for inclusion, participants must be at least 18 years old and no older than 80."
Has the FDA sanctioned Sonodynamic Therapy (5-ALA + LIFU) for use?
"Due to the nature of a Phase 1 trial, with limited evidence on safety and efficacy, our team at Power rated Sonodynamic Therapy (5-ALA + LIFU) as a 1."
Do I fulfill the criteria necessary for enrollment in this medical test?
"This clinical trial is seeking 11 glioblastoma patients aged between 18-80 to participate."
Are enrollment opportunities available for this investigation?
"Currently, this clinical investigation is not recruiting participants. It was originally posted on October 1st 2023 and the data was last updated on September 10th 2023. However, there are an abundance of other medical trials actively searching for patients with 1426 studies presently looking for candidates."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger